首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   316829篇
  免费   19497篇
  国内免费   1185篇
耳鼻咽喉   3611篇
儿科学   10202篇
妇产科学   7083篇
基础医学   44505篇
口腔科学   12179篇
临床医学   26915篇
内科学   70254篇
皮肤病学   7588篇
神经病学   29122篇
特种医学   9226篇
外国民族医学   30篇
外科学   34902篇
综合类   2158篇
现状与发展   2篇
一般理论   144篇
预防医学   31725篇
眼科学   5519篇
药学   20871篇
中国医学   1165篇
肿瘤学   20310篇
  2023年   2094篇
  2022年   3926篇
  2021年   8533篇
  2020年   5521篇
  2019年   7774篇
  2018年   9698篇
  2017年   7293篇
  2016年   7497篇
  2015年   8511篇
  2014年   11386篇
  2013年   14722篇
  2012年   22540篇
  2011年   23377篇
  2010年   12357篇
  2009年   10993篇
  2008年   18457篇
  2007年   19071篇
  2006年   17509篇
  2005年   17397篇
  2004年   15997篇
  2003年   14578篇
  2002年   12063篇
  2001年   6185篇
  2000年   5979篇
  1999年   5535篇
  1998年   2739篇
  1997年   2281篇
  1996年   2055篇
  1995年   1751篇
  1994年   1715篇
  1993年   1497篇
  1992年   3306篇
  1991年   3090篇
  1990年   2833篇
  1989年   2807篇
  1988年   2546篇
  1987年   2334篇
  1986年   2216篇
  1985年   2088篇
  1984年   1563篇
  1983年   1308篇
  1982年   835篇
  1981年   725篇
  1980年   707篇
  1979年   1103篇
  1978年   750篇
  1977年   607篇
  1975年   652篇
  1974年   645篇
  1973年   638篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
International Journal of Clinical Pharmacy - Background Drug-related problems (DRP) following hospital discharge may cause morbidity, mortality and hospital re-admissions. It is unclear whether a...  相似文献   
93.

Introduction

In the phase II/III KEYNOTE-010 study (ClinicalTrials.gov, NCT01905657), pembrolizumab significantly prolonged overall survival over docetaxel in patients with previously treated, programmed death ligand 1–expressing (tumor proportion score ≥ 1%), advanced NSCLC. Health-related quality of life (HRQoL) results are reported here.

Methods

Patients were randomized 1:1:1 to pembrolizumab 2 or 10 mg/kg every 3 weeks or docetaxel 75 mg/m2 every 3 weeks. HRQoL was assessed using European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLC) Core 30 (C30), EORTC QLQ–Lung Cancer 13 (LC13), and EuroQoL-5D. Key analyses included mean baseline-to-week-12 change in global health status (GHS)/quality of life (QoL) score, functioning and symptom domains, and time to deterioration in a QLQ-LC13 composite endpoint of cough, dyspnea, and chest pain.

Results

Patient reported outcomes compliance was high across all three instruments. Pembrolizumab was associated with better QLQ-C30 GHS/QoL scores from baseline to 12 weeks than docetaxel, regardless of pembrolizumab dose or tumor proportion score status (not significant). Compared with docetaxel, fewer pembrolizumab-treated patients had “deteriorated” status and more had “improved” status in GHS/QoL. Nominally significant improvement was reported in many EORTC symptom domains with pembrolizumab, and nominally significant worsening was reported with docetaxel. Significant prolongation in true time to deterioration for the QLQ-LC13 composite endpoint emerged for pembrolizumab 10 mg/kg compared to docetaxel (nominal two-sided p = 0.03), but not for the 2-mg/kg dose.

Conclusions

These findings suggest that HRQoL and symptoms are maintained or improved to a greater degree with pembrolizumab than with docetaxel in this NSCLC patient population.  相似文献   
94.
Journal of Digital Imaging - Vertebral Compression Fracture (VCF) occurs when the vertebral body partially collapses under the action of compressive forces. Non-traumatic VCFs can be secondary to...  相似文献   
95.
96.
97.
98.
99.
100.
Neutrophils can form neutrophil extracellular traps (NETs) to capture microbes and facilitate their clearance. NETs consist of decondensed chromatin decorated with anti-microbial proteins. Here, we describe the effect of neutrophil proteases on the protein content of NETs. We show that the neutrophil serine proteases degrade several neutrophil proteins associated with NETs. Interestingly, the anti-bacterial proteins associated with NETs, such as myeloperoxidase, calgranulin B and neutrophil elastase (NE), seem to be less susceptible to proteolytic degradation than other NET proteins, such as actin and MNDA. NETs have been proposed to play a role in autoimmune reactions. Our data demonstrate that a large number of the autoepitopes of NET proteins that are recognized by autoantibodies produced by systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients are also removed by the proteases. In conclusion, neutrophil serine proteases have a major impact on the NET proteome and the proteolytic changes of NET-associated proteins may counteract autoimmune reactions to NET components.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号